产品中心 / 产品类型 / ELISA试剂盒 / ELISA 抗体对

Rabbit anti-Human Galectin 1/LGALS1 mAb (CAP) (RM17806)

This standard curve is only for demonstration purposes. A standard curve should be generated for eachassay.

Placed at 37°C for 3 days, the stability of the standard curve all conformto CV <10%.

All(2)|
货号: RM17806
促销价:   ¥2100
抗体定制服务咨询

文献引用 (0)

详细信息

产品名称
Rabbit anti-Human Galectin 1/LGALS1 mAb (CAP)
货号
RM17806
免疫原
Recombinant Human Galectin 1/LGALS1
纯化方式
Affinity purification
同种型
Rabbit IgG
存储溶液
Supplied as a 0.2um filtered solution in PBS with 0.1%Braveds MB-1,PH 7.4.
CrossReactivity
/
存储条件
This antibody can be stored at 2℃-8℃ for one monthwithout detectable loss of activity. Antibody products are stable for twelve months fromdate of receipt when stored at -20℃ to -80℃. Preservative-Free.Avoid repeated freeze-thaw cycles.

* This package insert must be read in its entirety before using this product.

应用

Human Galectin 1/LGALS1 Sanwich ELISA Immunoassay

 Recommended
Concentration
Sample
ELISA Capture0.25-1ug/mLRabbit anti-Human Galectin 1/LGALS1 (CAP)(Cat. No.RM17806)
ELISA Detection0.0625-0.25ug/mLRabbit anti-Human Galectin 1/LGALS1 (DET)(Cat. No.RM17807)
Standard0.78-50ng/mLRecombinant Human Galectin 1/LGALS1 Protein

背景信息

Galectin 1 (Gal-1) is a 14 KDa β-galactose-binding mammalian lectin that is associated with many signaling pathways, immune responses associated with cancer progression, and immune disorders. Inhibition of human Gal-1 is considered as one of the potential approaches to treat cancer because it plays an important role in tumor progression and metastasis by regulating various biological functions, namely apoptosis, angiogenesis, migration, and cellular immune escape.Gal-1 is considered as a biomarker for diagnosis, prognosis, and therapeutic status.Overexpression of Gal-1 has been demonstrated in the progression of many types of cancer, such as osteosarcoma, breast, lung, prostate, melanoma, etc. Gal-1 greatly accelerates the binding kinetics of HIV-1 to susceptible cells, leading to faster viral entry and more robust viral replication through specific binding to CD4 cells. Therefore, Gal-1 is considered a promising molecular target for the development of new cancer and HIV therapeutics.Translated with www.DeepL.com/Translator (free version)

>